J.Jpn. Surg. Soc.
ISSN 1880-1129

[Abstract] [Full Text PDF] （in Japanese / 1637KB） [Members Only And Two Factor Auth.]

J.Jpn. Surg. Soc.. 93(9): 1111-1114, 1992

Report on the annual meeting

CLINICAL EVALUATION OF OPERATIVE AND NON-OPERATIVE TREATMENT IN HEPATOCELLULAR CARCINOMA WITH MAIN PORTAL VEIN TUMOR THROMBUS

Second Department of Surgery, School of Medicine, Tokai University, Isehara, Japan

Yutaka Tanaka, Yasuzo Otani, Masaru Tsukui, Kenichiro Goto, Hiroyasu Makuuchi, Tomoo Tajima, Toshio Mitomi

It has been well recognized that results of treatment in hepatocellular carcinoma with main portal vein tumor thrombus (Vp3 HCC) are very poor. But we tried aggressive transcatheter treatment (one shot or continuous hepatic arterial infusion, TAE) and hepatectomy with postoperative TAE in 52 cases by Vp3 HCC in recent 10 years. Analysis of the results disclosed that PR or CR cases were observed only in the series of continuous hepatic arterial infusion therapy. And cumulative survival rate was the best in the series of hepatectomy (50% survival interval is 18 months). We concluded that hapatectomy and resection of the tumor thrombus with postoperative TAE is the best treatment in Vp3 HCC.

<< To previous pageTo next page >>

To read the PDF file you will need Adobe Reader installed on your computer.